MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2019

Aug 21, 2019

ASX Announcement

22 August 2019

==> picture [612 x 88] intentionally omitted <==

Mach7 Contracts with St. Teresa’s Hospital in Hong Kong

Melbourne, Australia; 22 August 2019: Mach7 Technologies Limited (“Mach7” or “the Company”) (ASX:M7T) is pleased to announce it has signed a software license agreement with St. Teresa’s Hospital, a private hospital located in Kowloon, Hong Kong. The agreement has an estimated total contract revenue value of $950k across a 5-year term for the Company.

St. Teresa’s has licensed Mach7’s Enterprise Imaging Platform, Universal Worklist, QC Workflow and migration engine to consolidate its existing siloed Picture Archiving Communication Systems (PACS) into a single system. This initiative is expected to improve radiologist productivity through rapid access to relevant prior patient images, enabling both reading and quality control in different environments through web-based applications. This deal marks Mach7’s breakthrough into Hong Kong’s private hospital space, following on from Mach7’s contract with Hong Kong’s public hospital provider, Hospital Authority, in 2018.

“This deal represents the first Mach7 PACS replacement in Hong Kong for the private sector,” said Mike Lampron, Mach7 Managing Director. “We are gaining positive momentum in this region and this deal confirms the need for a flexible PACS solution that emphasises interoperability and can provide image access to all clinicians. St. Teresa’s is a well-respected hospital in Hong Kong, and we are delighted to help them expand their capabilities to better meet their patients' needs.”

About St. Teresa’s Hospital:

St. Teresa’s Hospital is a private Catholic Hospital located in Kowloon, Hong Kong. The 1050-bed hospital is a member of the Hong Kong Private Hospitals Association and offers a wide range of specialisations, including ENT, Orthopaedics, Cardiology, Neurology & Neurosurgery, Reconstructive Surgery, and more. www.sth.org.hk.

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) develops innovative data management solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s awardwinning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit Mach7t.com.

For more information, contact :

Jenni Pilcher Andrew Keys CFO & Company Secretary, Mach7 Investor Relations, Keys Thomas Associates jenni.pilcher@mach7t.com andrew.keys@keysthomas.com

==> picture [610 x 89] intentionally omitted <==